Study to Determine the Comparative Pharmacodynamics of Enoxaparin Sodium Biosimilar With That From Clexane

NCT07517289 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

26

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Participants Study
The Focus of the Study is to Determine the Comparative Pharmacodynamic of Enoxaparin Sodium With That of Clexane in Healthy Human Participants

Interventions

BIOLOGICAL: Enoxaparin 40 Mg/0.4 mL Injectable Solution

Sponsor

Egyptian International Pharmaceutical Industries Co